Distinguishing between immunophenotype and genotype in non-Hodgkin's lymphomas

Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population.

Blood·2022

The outcome of older adults with classic Hodgkin lymphoma in British Columbia.

Blood advances·2022

Tumor-associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B cell lymphoma.

The Journal of clinical investigation·2022

A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma.

Blood·2021

Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approach.

Blood advances·2021

MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma.

Haematologica·2021

Safety and efficacy of argatroban in patients with heparin-induced thrombocytopenia.

Current hematology reports·2006

The treatment of immune thrombocytopenic purpura in children.

Current hematology reports·2006

Volume-reduced platelet concentrates.

Current hematology reports·2006

Platelet transfusions in infants with necrotizing enterocolitis.

Current hematology reports·2006

Methods for counting platelets in severe thrombocytopenia.

Current hematology reports·2006

Flow cytometry for the diagnosis of autoimmune thrombocytopenia.

Current hematology reports·2006

Advances in γδ T Cells: Cutaneous Biology and Therapeutic Potential for Skin Neoplasms.

The Journal of dermatology·2026

Revisiting tumor immunogenicity through the lens of mutant p53: Implications for cancer immunotherapy.

Apoptosis : an international journal on programmed cell death·2026

Intersession reliability of transcranial magnetic stimulation measures of interhemispheric inhibition.

Neuroscience·2026

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Frontiers in oncology·2026

Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response.

Nature reviews. Cancer·2026

Circulating levels of TL1A and its decoy receptor DcR3 in systemic sclerosis.

Clinical rheumatology·2026

Related Experiment Videos

Distinguishing between immunophenotype and genotype in non-Hodgkin's lymphomas

Related Concept Videos

Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population.

The outcome of older adults with classic Hodgkin lymphoma in British Columbia.

Tumor-associated antigen PRAME exhibits dualistic functions that are targetable in diffuse large B cell lymphoma.

A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma.

Outcome of limited-stage nodular lymphocyte-predominant Hodgkin lymphoma and the impact of a PET-adapted approach.

MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma.

Safety and efficacy of argatroban in patients with heparin-induced thrombocytopenia.

The treatment of immune thrombocytopenic purpura in children.

Volume-reduced platelet concentrates.

Platelet transfusions in infants with necrotizing enterocolitis.

Methods for counting platelets in severe thrombocytopenia.

Flow cytometry for the diagnosis of autoimmune thrombocytopenia.

Advances in γδ T Cells: Cutaneous Biology and Therapeutic Potential for Skin Neoplasms.

Revisiting tumor immunogenicity through the lens of mutant p53: Implications for cancer immunotherapy.

Intersession reliability of transcranial magnetic stimulation measures of interhemispheric inhibition.

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response.

Circulating levels of TL1A and its decoy receptor DcR3 in systemic sclerosis.

Related Experiment Videos

Distinguishing between immunophenotype and genotype in non-Hodgkin's lymphomas

Related Concept Videos

Related Articles